Skip to content

Evaluation the effect of probiotic on drug-resistant epilepsy

Evaluation the effect of probiotic supplementation on clinical symptoms and biochemical indices in children with drug-resistant epilepsy

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170615034549N2
Enrollment
40
Registered
2020-06-17
Start date
2019-10-27
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug resistant epilepsy. Epilepsy and recurrent seizure

Interventions

Intervention group: children with Drug resistant epilepsy that are received oral probiotic supplementation as daily with 2 month. The probiotic supplement is Prokid from Gostaresh Milad Farmed Co., wh

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 15 Years

Inclusion criteria

Inclusion criteria: Patients with a diagnosis of refractory epilepsy. Patients are between 3 and 15 years old. children who have a medical record with a medical doctor and have been referred to the pediatric neurosurgery clinic of Shahid Beheshti Hospital for treatment. They have had at least one seizure in the past three months.

Exclusion criteria

Exclusion criteria: Children that the cause of their seizures are secondary such as electrolyte imbalances Children with underlying, genetic or progressive brain diseases. Children who have had probiotic use for one month before the study. Children who take antibiotics with any reason for one month before the study. Children who take any immunosuppressant medication with any reason for one month before the study. Children who take any vitamin or mineral supplement except vitamin D

Design outcomes

Primary

MeasureTime frame
Seizure frequency. Timepoint: before and after probiotic treatment. Method of measurement: asking frequency of seizure frequency.

Secondary

MeasureTime frame
Blood indices(Sodium- calcium - potassium - magnesium - hepatic enzymes including alkaline phosphatase, AST and ALT- bilirubin - creatinin). Timepoint: before and after. Method of measurement: Measurement of venous blood sample.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ahmad Talebian

Kashan University of Medical Sciences

talebian_a@kaums.ac.ir+98 31 5554 0027

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026